| Amgen Switzerland AG - Kyprolis 30 mg, Pulver zur Herstellung einer Infusionslösung |
| 65690 | | 03 | | Kyprolis 30 mg | | Pulver zur Herstellung einer Infusionslösung | | L01XG02 | | Carfilzomib | | 24.01.2017 | | |
|
| Composition |
| Praeparatio cryodesiccata: carfilzomibum 30 mg, sulfobutylbetadexum natricum 1500 mg, acidum citricum, natrii hydroxidum ad pH, nitrogenium, pro vitro corresp. natrium 109 mg. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Lyophilisate | | | | | | | | Active Agent | Dose |
|---|
| Carfilzomibum | 30 mg |
| | BAG: Active Agent | Dose |
|---|
| Carfilzomibum | 30 mg |
| | | | Inactive agents | Dose |
|---|
| Citric Acid | | | Natrii Hydroxidum ad Ph | | | Nitrogenium | | | Sulfobutylbetadexum Natricum | 1500 mg |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | | 512.54 | 573.85 | A | SL | Yes |
|
